$XRAY
DENTSPLY SIRONA Inc.

2022 Q1 Form 10-Q Financial Statement

#000114036122040133 Filed on November 07, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2020 Q1
Revenue $965.0M $874.0M
YoY Change -6.04% -7.63%
Cost Of Revenue $450.0M $406.0M
YoY Change 0.45% -9.07%
Gross Profit $515.0M $468.0M
YoY Change -11.05% -6.34%
Gross Profit Margin 53.37% 53.55%
Selling, General & Admin $374.0M $359.0M
YoY Change -2.86% -16.88%
% of Gross Profit 72.62% 76.71%
Research & Development $45.00M $34.00M
YoY Change 21.62%
% of Gross Profit 8.74% 7.26%
Depreciation & Amortization $84.00M $32.00M
YoY Change 162.5% -8.31%
% of Gross Profit 16.31% 6.84%
Operating Expenses $419.0M $393.0M
YoY Change -0.71% -9.01%
Operating Profit $96.00M -$125.0M
YoY Change -37.66% -364.27%
Interest Expense -$12.00M $7.000M
YoY Change -185.71% -16.67%
% of Operating Profit -12.5%
Other Income/Expense, Net $2.000M $2.000M
YoY Change -77.78% -85.51%
Pretax Income $83.00M -$130.0M
YoY Change -44.3% -341.64%
Income Tax $18.00M $10.00M
% Of Pretax Income 21.69%
Net Earnings $65.00M -$140.0M
YoY Change -44.44% -457.14%
Net Earnings / Revenue 6.74% -16.02%
Basic Earnings Per Share $0.32 -$0.63
Diluted Earnings Per Share $298.4K -$0.63
COMMON SHARES
Basic Shares Outstanding 217.6M shares 220.9M shares
Diluted Shares Outstanding 217.8M 220.9M shares

Balance Sheet

Concept 2022 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $374.0M $236.0M
YoY Change 17.61% 4.89%
Cash & Equivalents $374.0M $235.9M
Short-Term Investments
Other Short-Term Assets $264.0M $270.0M
YoY Change 12.34% -8.16%
Inventory $541.0M $590.5M
Prepaid Expenses
Receivables $707.0M $709.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.886B $1.805B
YoY Change 11.2% 0.53%
LONG-TERM ASSETS
Property, Plant & Equipment $975.0M $776.6M
YoY Change 28.63% -9.05%
Goodwill $3.944B $3.192B
YoY Change -0.2% -6.1%
Intangibles $2.228B $2.045B
YoY Change -9.47% -12.01%
Long-Term Investments
YoY Change
Other Assets $127.0M $92.50M
YoY Change 24.51% 37.65%
Total Long-Term Assets $7.274B $6.253B
YoY Change -2.24% -8.16%
TOTAL ASSETS
Total Short-Term Assets $1.886B $1.805B
Total Long-Term Assets $7.274B $6.253B
Total Assets $9.160B $8.058B
YoY Change 0.25% -6.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $285.0M $271.1M
YoY Change 0.71% 0.78%
Accrued Expenses $618.0M $522.9M
YoY Change 10.95% 2.31%
Deferred Revenue $64.00M $26.60M
YoY Change 45.45% -7.32%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $347.0M $33.00M
YoY Change 5.79% 57.14%
Total Short-Term Liabilities $1.303B $891.5M
YoY Change 7.51% 2.4%
LONG-TERM LIABILITIES
Long-Term Debt $1.872B $1.421B
YoY Change -2.65% -8.02%
Other Long-Term Liabilities $673.0M $482.5M
YoY Change 25.56% 15.24%
Total Long-Term Liabilities $2.545B $1.904B
YoY Change 3.5% -3.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.303B $891.5M
Total Long-Term Liabilities $2.545B $1.904B
Total Liabilities $4.254B $3.368B
YoY Change 1.12% -3.63%
SHAREHOLDERS EQUITY
Retained Earnings $1.556B $1.242B
YoY Change 17.17% -0.22%
Common Stock $3.000M $2.600M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.640B $2.399B
YoY Change 6.97% 13.01%
Treasury Stock Shares $49.00M 45.40M shares
Shareholders Equity $4.906B $4.688B
YoY Change
Total Liabilities & Shareholders Equity $9.160B $8.058B
YoY Change 0.25% -6.35%

Cashflow Statement

Concept 2022 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $65.00M -$140.0M
YoY Change -44.44% -457.14%
Depreciation, Depletion And Amortization $84.00M $32.00M
YoY Change 162.5% -8.31%
Cash From Operating Activities $93.00M -$10.00M
YoY Change 89.8% -134.13%
INVESTING ACTIVITIES
Capital Expenditures -$44.00M -$25.60M
YoY Change 46.67% -24.48%
Acquisitions $0.00 $0.00
YoY Change -100.0%
Other Investing Activities $1.000M $10.10M
YoY Change -101.37% -52.36%
Cash From Investing Activities -$43.00M -$16.00M
YoY Change -58.25% 25.98%
FINANCING ACTIVITIES
Cash Dividend Paid $24.00M $22.00M
YoY Change 9.09% 12.82%
Common Stock Issuance & Retirement, Net $140.0M
YoY Change
Debt Paid & Issued, Net $2.000M $1.000M
YoY Change -47.37%
Cash From Financing Activities -10.00M -$130.0M
YoY Change -81.13% 31.05%
NET CHANGE
Cash From Operating Activities 93.00M -$10.00M
Cash From Investing Activities -43.00M -$16.00M
Cash From Financing Activities -10.00M -$130.0M
Net Change In Cash 40.00M -$169.0M
YoY Change -133.33% 100.71%
FREE CASH FLOW
Cash From Operating Activities $93.00M -$10.00M
Capital Expenditures -$44.00M -$25.60M
Free Cash Flow $137.0M $15.60M
YoY Change 73.42% -75.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2319000000
CY2022Q1 us-gaap Goodwill
Goodwill
3944000000
CY2021Q4 us-gaap Goodwill
Goodwill
3976000000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
128000000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
121000000
CY2022Q1 us-gaap Assets
Assets
9172000000
CY2021Q4 us-gaap Assets
Assets
9239000000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1026000000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
448000000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
277000000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
262000000
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000818479
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
0-16211
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
DENTSPLY SIRONA Inc.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
39-1434669
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
13320 Ballantyne Corporate Place
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Charlotte
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
28277-3607
CY2022Q1 dei City Area Code
CityAreaCode
844
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
848-0137
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $.01 per share
CY2022Q1 dei Trading Symbol
TradingSymbol
XRAY
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
214911886
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
969000000
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
447000000
CY2022Q1 us-gaap Gross Profit
GrossProfit
521000000
CY2021Q1 us-gaap Gross Profit
GrossProfit
579000000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
376000000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
386000000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
45000000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
40000000
CY2022Q1 us-gaap Restructuring Charges
RestructuringCharges
3000000
CY2021Q1 us-gaap Restructuring Charges
RestructuringCharges
3000000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
97000000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
150000000
CY2022Q1 us-gaap Interest Expense
InterestExpense
12000000
CY2021Q1 us-gaap Interest Expense
InterestExpense
14000000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
694000000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
760000000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
32000000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1852000000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
771000000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
773000000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
204000000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9000000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
87000000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
145000000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
33000000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
69000000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
112000000
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
69000000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
112000000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.51
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
217000000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218800000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
217800000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
219900000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
69000000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
112000000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-48000000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-99000000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
10000000
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
5000000
CY2022Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1000000
CY2021Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-4000000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-37000000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-90000000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
22000000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
32000000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
22000000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
374000000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
339000000
CY2022Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
707000000
CY2021Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
750000000
CY2022Q1 us-gaap Inventory Net
InventoryNet
553000000
CY2021Q4 us-gaap Inventory Net
InventoryNet
515000000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
263000000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
248000000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
1897000000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
3000000
CY2022Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
54000000
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
57000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
264500000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
198000000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2228000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
264500000
CY2022Q1 us-gaap Minority Interest
MinorityInterest
1000000
CY2021Q4 us-gaap Minority Interest
MinorityInterest
1000000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4864000000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4997000000
CY2022Q1 us-gaap Debt Current
DebtCurrent
347000000
CY2021Q4 us-gaap Debt Current
DebtCurrent
182000000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1372000000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1261000000
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1872000000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1913000000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
157000000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
149000000
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
389000000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
391000000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
518000000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
528000000
CY2022Q1 us-gaap Liabilities
Liabilities
4308000000
CY2021Q4 us-gaap Liabilities
Liabilities
4242000000
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
3000000
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
215500000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
217400000
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6573000000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6606000000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1556000000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1514000000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-629000000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-592000000
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
49000000
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
47100000
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
2640000000
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2535000000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
4863000000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4996000000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9172000000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9239000000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4997000000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
69000000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-37000000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5000000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11000000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
2000000
CY2022Q1 us-gaap Accelerated Share Repurchase Program Adjustment
AcceleratedShareRepurchaseProgramAdjustment
-150000000
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-6000000
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.125
CY2022Q1 us-gaap Dividends Cash
DividendsCash
27000000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4864000000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4935000000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
112000000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-90000000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
33000000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13000000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
3000000
CY2021Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
90000000
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-4000000
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1
CY2021Q1 us-gaap Dividends Cash
DividendsCash
22000000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4890000000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
69000000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
112000000
CY2022Q1 us-gaap Depreciation
Depreciation
29000000
CY2021Q1 us-gaap Depreciation
Depreciation
32000000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
55000000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
56000000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-14000000
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3000000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
11000000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
13000000
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2000000
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-16000000
CY2022Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0
CY2021Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
13000000
CY2022Q1 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-34000000
CY2021Q1 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-13000000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
41000000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
51000000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
17000000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
26000000
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-3000000
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
13000000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
19000000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-16000000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-53000000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-79000000
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
3000000
CY2021Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-5000000
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-7000000
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
13000000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-5000000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
93000000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
49000000
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
44000000
CY2021Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
30000000
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
92000000
CY2022Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0
CY2021Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
19000000
CY2022Q1 us-gaap Proceeds From Derivative Instrument Investing Activities
ProceedsFromDerivativeInstrumentInvestingActivities
1000000
CY2021Q1 us-gaap Proceeds From Derivative Instrument Investing Activities
ProceedsFromDerivativeInstrumentInvestingActivities
0
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-43000000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-103000000
CY2022Q1 xray Accelerated Share Repurchase Agreement Cash Paid
AcceleratedShareRepurchaseAgreementCashPaid
150000000
CY2021Q1 xray Accelerated Share Repurchase Agreement Cash Paid
AcceleratedShareRepurchaseAgreementCashPaid
0
CY2022Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
163000000
CY2021Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
30000000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
90000000
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
24000000
CY2021Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
22000000
CY2022Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
5000000
CY2021Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
4000000
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2000000
CY2021Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5000000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
33000000
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-7000000
CY2021Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-8000000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10000000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-53000000
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-13000000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
35000000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-120000000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
339000000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
438000000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
374000000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
318000000
CY2022Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
32000000
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div> <div style="text-align:justify"><br/> </div> <div style="display:none;"><br/></div> <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of Net sales and expense during the reporting period. Actual results could differ materially from those estimates.</span></div> <div style="display:none;"><br/></div> <div style="text-align:justify;text-indent:18pt"><br/> </div> <div style="display:none;"><br/></div> <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specifically, for the three months ended March 31, 2022, some of these estimates and assumptions continue to be based on an ongoing evaluation of expected future impacts from the COVID-19 pandemic. The full extent to which the COVID-19 pandemic will directly or indirectly have a negative material impact on the Company’s financial condition, liquidity, or results of operations in future periods is highly uncertain and difficult to predict. More specifically, although demand for the Company’s products has largely recovered from the impact of rigorous preventive measures implemented at the outset of the pandemic, it continues to be affected by social distancing guidelines, dental practice safety protocols which reduce patient traffic, and some lingering patient reluctance to seek dental care. Also, impacts from the pandemic continue to be experienced in the form of more recent shortages and higher prices of raw materials such as electronic components, higher related transportation costs, and labor shortages. In the first quarter of 2022, the Company has experienced supply chain constraints, which has impacted its ability to timely produce and deliver certain products, and has also resulted in increases in shipping rates. To address these issues, the Company has taken steps to mitigate the impact of these trends, including continued emphasis on cost reduction and supply chain efficiencies. However, uncertainties remain regarding how long these impacts will continue, whether customer demand will fully return to pre-COVID-19 levels upon lifting of remaining government restrictions, or whether future variants of the virus may have an adverse impact on demand in affected markets.</span></div>
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
969000000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1026000000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
969000000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1026000000
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
64000000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
68000000
CY2022Q1 us-gaap Purchase Obligation Due In Fifth Year
PurchaseObligationDueInFifthYear
43000000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11000000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13000000
CY2022Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1000000
CY2021Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2000000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
69000000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
112000000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
217000000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218800000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.51
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
69000000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
112000000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
217000000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218800000
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
800000
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1100000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
217800000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
219900000
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1900000
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
800000
CY2021Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1000000000
CY2022Q1 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
770000000
CY2022Q1 us-gaap Purchase Obligation Due After Fifth Year
PurchaseObligationDueAfterFifthYear
0
CY2022Q1 us-gaap Purchase Obligation
PurchaseObligation
319000000
CY2022Q1 us-gaap Accelerated Share Repurchases Settlement Payment Or Receipt
AcceleratedShareRepurchasesSettlementPaymentOrReceipt
-150000000
CY2022Q1 xray Accelerated Share Repurchases Initial Shares Received
AcceleratedShareRepurchasesInitialSharesReceived
2400000
CY2022Q1 us-gaap Accelerated Share Repurchases Initial Price Paid Per Share
AcceleratedShareRepurchasesInitialPricePaidPerShare
50.44
CY2022Q1 xray Accelerated Share Repurchases Value Of Shares As Percentage Of Contract Value
AcceleratedShareRepurchasesValueOfSharesAsPercentageOfContractValue
0.80
CY2022Q1 xray Accelerated Share Repurchases Delivery Of Common Shares
AcceleratedShareRepurchasesDeliveryOfCommonShares
120000000
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
969000000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1026000000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
87000000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
145000000
CY2022Q1 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
142000000
CY2021Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
139000000
CY2022Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
78000000
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
72000000
CY2022Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
333000000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
304000000
CY2022Q1 us-gaap Inventory Net
InventoryNet
553000000
CY2021Q4 us-gaap Inventory Net
InventoryNet
515000000
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
86000000
CY2022Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
86000000
CY2022Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
3000000
CY2021Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
1000000
CY2022Q1 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
9000000
CY2021Q4 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
0
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
3000000
CY2021Q4 us-gaap Restructuring Reserve
RestructuringReserve
18000000
CY2022Q1 us-gaap Restructuring Charges
RestructuringCharges
3000000
CY2022Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
5000000
CY2022Q1 us-gaap Restructuring Reserve
RestructuringReserve
16000000
CY2022Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
41000000
CY2022Q1 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0
CY2022Q1 us-gaap Derivative Assets
DerivativeAssets
41000000
CY2022Q1 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
0
CY2022Q1 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
32000000
CY2022Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
25000000
CY2022Q1 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0
CY2022Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
25000000
CY2022Q1 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
9000000
CY2022Q1 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
0
CY2022Q1 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
16000000
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
31000000
CY2021Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0
CY2021Q4 us-gaap Derivative Assets
DerivativeAssets
31000000
CY2021Q4 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
9000000
CY2021Q4 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
0
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
22000000
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
12000000
CY2021Q4 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
12000000
CY2021Q4 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
9000000
CY2021Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
2893000000
CY2021Q4 us-gaap Goodwill
Goodwill
3976000000
CY2022Q1 xray Goodwill Foreign Currency Translation Gain Loss And Other
GoodwillForeignCurrencyTranslationGainLossAndOther
-32000000
CY2022Q1 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
1000000
CY2021Q1 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-1000000
CY2022Q1 us-gaap Income Tax Reconciliation Disposition Of Business
IncomeTaxReconciliationDispositionOfBusiness
4000000
CY2022Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
399000000
CY2022Q1 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.012
CY2022Q1 us-gaap Goodwill Gross
GoodwillGross
6837000000
CY2022Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
2893000000
CY2022Q1 us-gaap Goodwill
Goodwill
3944000000
CY2022Q1 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
35000000
CY2022Q1 us-gaap Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
36000000
CY2021Q4 us-gaap Goodwill Gross
GoodwillGross
6869000000
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3090000000
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1458000000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1632000000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3125000000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1418000000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1707000000
CY2022Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
596000000
CY2022Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
596000000
CY2021Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
612000000
CY2021Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
612000000
CY2022Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
3686000000
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1458000000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2228000000
CY2021Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
3737000000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1418000000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2319000000
CY2018Q3 us-gaap Loss Contingency New Claims Filed Number
LossContingencyNewClaimsFiledNumber
2
CY2022Q1 us-gaap Income Tax Effects Allocated Directly To Equity Employee Stock Options
IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions
546000000
CY2022Q1 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
119000000
CY2022Q1 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
86000000

Files In Submission

Name View Source Status
0001140361-22-040133-index-headers.html Edgar Link pending
0001140361-22-040133-index.html Edgar Link pending
0001140361-22-040133.txt Edgar Link pending
0001140361-22-040133-xbrl.zip Edgar Link pending
brhc10043534_10q.htm Edgar Link pending
brhc10043534_ex31-1.htm Edgar Link pending
brhc10043534_ex31-2.htm Edgar Link pending
brhc10043534_ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
brhc10043534_10q_htm.xml Edgar Link completed
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xray-20220331.xsd Edgar Link pending
xray-20220331_cal.xml Edgar Link unprocessable
xray-20220331_def.xml Edgar Link unprocessable
xray-20220331_lab.xml Edgar Link unprocessable
xray-20220331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable